Ute A Kopp
Overview
Explore the profile of Ute A Kopp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heine J, Kopp U, Klag J, Ploner C, Pruss H, Finke C
Ann Neurol
. 2021 Oct;
90(6):949-961.
PMID: 34595771
Objective: Cognitive dysfunction is a core symptom of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis, but detailed studies on prevalence, characteristics of cognitive deficits, and the potential for recovery are missing. Here, we...
2.
Herm J, Schirdewan A, Koch L, Wutzler A, Fiebach J, Endres M, et al.
J Clin Neurosci
. 2020 Jan;
73:168-172.
PMID: 31992513
Atrial fibrillation (AF) is associated with cognitive decline and dementia irrespective of AF-related ischemic stroke. We investigated whether AF burden after ablation in patients with symptomatic paroxysmal AF has an...
3.
Gruber D, Calmbach L, Kuhn A, Krause P, Kopp U, Schneider G, et al.
J Neural Transm (Vienna)
. 2019 Jan;
126(3):309-318.
PMID: 30684055
Normal cognition is an established selection criteria for subthalamic (STN) deep brain stimulation (DBS) in Parkinson's disease (PD), while concern has been raised as to aggravated cognitive decline in PD...
4.
Heine J, Pruss H, Kopp U, Wegner F, Then Bergh F, Munte T, et al.
J Neurol Neurosurg Psychiatry
. 2018 Jun;
89(11):1191-1199.
PMID: 29886429
Objective: Hippocampal inflammation in anti-LGI1 encephalitis causes memory deficits, seizures and behavioural abnormalities. Recent findings suggest that extralimbic brain areas are additionally affected and that patients also suffer from non-limbic...
5.
Finke C, Pruss H, Heine J, Reuter S, Kopp U, Wegner F, et al.
JAMA Neurol
. 2016 Nov;
74(1):50-59.
PMID: 27893017
Importance: Limbic encephalitis with leucine-rich, glioma-inactivated 1 (LGI1) antibodies is one of the most frequent variants of autoimmune encephalitis with antibodies targeting neuronal surface antigens. However, the neuroimaging pattern and...
6.
Finke C, Kopp U, Pajkert A, Behrens J, Leypoldt F, Wuerfel J, et al.
Biol Psychiatry
. 2015 Apr;
79(9):727-734.
PMID: 25866294
Background: The majority of patients with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis suffer from persistent memory impairment despite unremarkable routine clinical magnetic resonance imaging. With improved acute care in these patients, neurocognitive...
7.
Herm J, Fiebach J, Koch L, Kopp U, Kunze C, Wollboldt C, et al.
Circ Arrhythm Electrophysiol
. 2013 Aug;
6(5):843-50.
PMID: 23989301
Background: MRI-detected brain lesions are common after left atrial catheter ablation for symptomatic atrial fibrillation. The clinical relevance of these acute ischemic lesions is not fully understood, but ablation-related cerebral...
8.
Fuhrer H, Kupsch A, Halbig T, Kopp U, Scherer P, Gruber D
J Neural Transm (Vienna)
. 2013 Aug;
121(2):147-51.
PMID: 23959161
Mixed dopaminergic medication, comprising dopamine agonists and levodopa, may affect habit-learning in patients with Parkinson’s disease (PD). However, the specific impact of levodopa on this effect is unknown. We assessed...
9.
Finke C, Kopp U, Scheel M, Pech L, Soemmer C, Schlichting J, et al.
Ann Neurol
. 2013 May;
74(2):284-96.
PMID: 23686722
Objective: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune encephalitis with a characteristic neuropsychiatric syndrome and severe and prolonged clinical courses. In contrast, standard clinical magnetic resonance imaging (MRI) remains normal...
10.
Haeusler K, Koch L, Herm J, Kopp U, Heuschmann P, Endres M, et al.
J Cardiovasc Electrophysiol
. 2012 Aug;
24(1):14-21.
PMID: 22913568
Background: Left atrial catheter ablation (LACA) is an established therapeutic approach to abolish symptomatic atrial fibrillation (AF). Objective: Based on the prospective MACPAF study (clinicaltrials.gov NCT01061931) we report the rate...